SPOTLIGHT: GSK buys Reliant Pharma for $1.65B

by admin |

Breaking news: GlaxoSmithKline will pay $1.65 billion to buy U.S.-based Reliant Pharmaceuticals, a privately held drug maker that specializes in cardiovascular remedies. Reliant recently posted 9-month revenues of $341 million. Release | Report

Suggested Articles

artists conception 2019
Manufacturing

Real estate group creating gene therapy CDMO at former GSK site

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

by Eric Palmer
amgen
Pharma Asia

Amgen amps up in Asia with full control of Astellas Japanese JV

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

by Angus Liu
viagra
Pharma

Pfizer's Upjohn strikes generic Viagra deal with Roman

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.

by Kyle Blankenship